Published in Stem Cells on February 01, 2010
Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev (2010) 5.83
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Res (2013) 1.66
Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res (2011) 1.62
Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. PLoS One (2013) 0.97
PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia. Differentiation (2011) 0.97
Prostate cancer stem cells. Clin Genitourin Cancer (2012) 0.96
TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One (2010) 0.95
Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration. Am J Pathol (2012) 0.87
Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. Cancer Res (2012) 0.85
Phosphodiesterase 4D inhibitors limit prostate cancer growth potential. Mol Cancer Res (2014) 0.85
SOX2 expression in the developing, adult, as well as, diseased prostate. Prostate Cancer Prostatic Dis (2014) 0.83
SPARCL1 suppresses metastasis in prostate cancer. Mol Oncol (2013) 0.81
NF-κB and androgen receptor variant expression correlate with human BPH progression. Prostate (2015) 0.81
Identification of an antibody fragment specific for androgen-dependent prostate cancer cells. BMC Biotechnol (2014) 0.80
Recent advances in prostate development and links to prostatic diseases. Wiley Interdiscip Rev Syst Biol Med (2013) 0.79
RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. Clin Cancer Res (2014) 0.78
Isolation and analysis of discreet human prostate cellular populations. Differentiation (2015) 0.77
Modeling stromal-epithelial interactions in disease progression. Discov Med (2010) 0.76
Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo. Oncotarget (2016) 0.75
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-Reductase Inhibition in Prostate Epithelial Cells. J Biol Chem (2016) 0.75
Spontaneous immortalization of human dermal microvascular endothelial cells. World J Stem Cells (2010) 0.75
The many ways to make a luminal cell and a prostate cancer cell. Endocr Relat Cancer (2015) 0.75
NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Prostate (2016) 0.75
Modeling tissue morphogenesis and cancer in 3D. Cell (2007) 7.49
Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods (2007) 7.43
The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A (2005) 4.12
High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci U S A (2004) 3.75
Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis (1997) 2.97
Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol (2002) 2.96
Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim (1995) 2.63
Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res (2001) 2.50
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development (2005) 2.31
Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res (2007) 2.22
Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl (1989) 2.12
Cell differentiation lineage in the prostate. Differentiation (2001) 2.01
Tissue-specific expression of murine Nkx3.1 in the male urogenital system. Dev Dyn (1997) 1.90
Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation (1998) 1.86
Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem (1996) 1.85
Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science (2001) 1.76
Prostatic growth and development are regulated by FGF10. Development (1999) 1.74
Mouse urogenital development: a practical approach. Differentiation (2003) 1.59
In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J Cell Biochem (2004) 1.57
Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. Dev Biol (2002) 1.54
FGF-10 plays an essential role in the growth of the fetal prostate. Dev Biol (2003) 1.53
Stem/progenitor and intermediate cell types and the origin of human prostate cancer. Differentiation (2005) 1.40
hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol (2008) 1.40
Epithelio-mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation. Anat Rec (1972) 1.35
Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate (2007) 1.31
The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment. Prostate (1999) 1.25
Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One (2009) 1.24
Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem (2008) 1.23
The prostate: development and physiology. Radiol Clin North Am (2000) 1.22
15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Am J Pathol (1999) 1.17
Methodologies in assaying prostate cancer stem cells. Methods Mol Biol (2009) 1.16
Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat (Basel) (1996) 1.14
A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. PLoS One (2008) 1.14
Coupled analysis of gene expression and chromosomal location. Genomics (2005) 1.10
Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development. J Urol (1999) 1.09
Hoxa-10 deficient male mice exhibit abnormal development of the accessory sex organs. Dev Dyn (1999) 1.03
Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat. Acta Anat (Basel) (1996) 1.03
Immortalization protocols used in cell culture models of human breast morphogenesis. Cell Mol Life Sci (2004) 1.02
Tissue interactions between epithelium and mesenchyme of urogenital and integumental origin. Anat Rec (1972) 0.99
Correlation of early cytodifferentiation of the human fetal prostate and Leydig cells. Anat Rec (1980) 0.94
Full complexity genomic hybridization on 60-mer oligonucleotide microarrays for array comparative genomic hybridization (aCGH). Methods Mol Biol (2008) 0.93
Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease. Genome Biol (2007) 0.92
The effects of interferons on the activity of alpha-glycerolphosphate dehydrogenase in benign prostatic hyperplasia cells in primary culture. J Urol (1987) 0.79
The androgen-dependent rat prostate protein, probasin, is a heparin-binding protein that co-purifies with heparin-binding growth factor-1. In Vitro Cell Dev Biol (1989) 0.78
Effects of flutamide and hydroxy-flutamide on the growth of human benign prostatic hyperplasia cells in primary culture: a preliminary report. Anticancer Res (1992) 0.77
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med (2011) 6.85
Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res (2005) 5.87
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol (2012) 3.08
Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res (2007) 3.00
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell (2012) 2.69
Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (2009) 2.59
NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol (2008) 2.44
Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer (2003) 2.43
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene (2005) 2.35
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development (2005) 2.31
Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res (2002) 2.29
Role of stroma in carcinogenesis of the prostate. Differentiation (2002) 2.26
Cluster analysis of mass spectrometry data reveals a novel component of SAGA. Mol Cell Biol (2004) 2.22
Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol (2009) 2.20
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol (2004) 2.19
PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res (2008) 2.16
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res (2006) 2.13
Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res (2006) 2.05
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res (2007) 2.02
Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res (2005) 1.88
MicroRNA regulation of cancer stem cells. Cancer Res (2011) 1.84
Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. J Clin Invest (2012) 1.63
Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res (2011) 1.62
Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome. Cell (2006) 1.61
Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate (2005) 1.57
Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J Biol Chem (2002) 1.57
Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J Biol Chem (2007) 1.57
Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res (2005) 1.56
Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res (2012) 1.55
IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev (2008) 1.54
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells. Eur Urol (2013) 1.51
Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate (2005) 1.49
Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network. Prostate (2014) 1.49
Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med (2004) 1.47
Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene (2003) 1.46
Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death. Mol Cell Biol (2004) 1.46
miR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway. Curr Vasc Pharmacol (2016) 1.42
Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res (2008) 1.36
Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res (2006) 1.36
Bax-dependent regulation of Bak by voltage-dependent anion channel 2. J Biol Chem (2005) 1.32
Steroid hormones stimulate human prostate cancer progression and metastasis. Int J Cancer (2006) 1.32
Comparative sequence and x-inactivation analyses of a domain of escape in human xp11.2 and the conserved segment in mouse. Genome Res (2004) 1.29
Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer (2008) 1.26
NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Cancer Res (2004) 1.24
Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene (2005) 1.23
Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem (2008) 1.23
Conductivity for soot sensing: possibilities and limitations. Anal Chem (2012) 1.21
The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach. Cancer Res (2009) 1.21
Cancer stem cells and radioresistance. Int J Radiat Biol (2014) 1.20
Identification and characterization of Bimgamma, a novel proapoptotic BH3-only splice variant of Bim. Cancer Res (2002) 1.20
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab Invest (2005) 1.19
Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants. J Biol Chem (2003) 1.18
Role for stromal heterogeneity in prostate tumorigenesis. Cancer Res (2011) 1.18
Methodologies in assaying prostate cancer stem cells. Methods Mol Biol (2009) 1.16
Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem (2002) 1.15
A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. PLoS One (2008) 1.14
miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer. J Exp Clin Cancer Res (2014) 1.12
A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease. Genomics (2002) 1.11
Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Mol Cancer Res (2012) 1.10
Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients. Oral Oncol (2009) 1.10
Directed differentiation of embryonic stem cells into bladder tissue. Dev Biol (2007) 1.10
Molecular, cellular and developmental biology of urothelium as a basis of bladder regeneration. Differentiation (2005) 1.09
Divergent strategies for controlling the nuclear membrane satisfy geometric constraints during nuclear division. Curr Biol (2011) 1.08
Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression. Cancer Res (2007) 1.08
Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci U S A (2002) 1.07
Nasopharyngeal teratoma associated with cleft palate in newborn: report of 2 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 1.06
CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer. Cancer Res (2013) 1.05
Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation (2008) 1.04
Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis (2012) 1.03
Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol (2008) 1.02
New insights into prostate cancer stem cells. Cell Cycle (2013) 1.02
Transcriptional remodeling of rapidly stimulated HL-1 atrial myocytes exhibits concordance with human atrial fibrillation. J Mol Cell Cardiol (2009) 1.01
Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett (2004) 1.00
Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity. J Neurooncol (2009) 0.99
Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Neoplasia (2012) 0.99
The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor. Mol Cell Biol (2012) 0.98
Prostate cancer stem cells and their potential roles in metastasis. J Surg Oncol (2011) 0.98
Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells. Oncogene (2005) 0.97
PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia. Differentiation (2011) 0.97
Targeting the tumor stroma as a novel therapeutic approach for prostate cancer. Adv Pharmacol (2012) 0.96
An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity. Mol Cell Biol (2006) 0.96
TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One (2010) 0.95
Web-based interrogation of gene expression signatures using EXALT. BMC Bioinformatics (2009) 0.94
Diagnosis and endovascular treatment of spontaneous direct carotid-cavernous fistula. Chin Med J (Engl) (2008) 0.93
Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease. Genome Biol (2007) 0.92
Quantitation of apoptotic activity following castration in human prostatic tissue in vivo. Prostate (2003) 0.92